Albertsons Companies reported a fourth-quarter net loss of $480.8 million, or 94 cents a share, versus net income of $171.8 million, or 29 cents a share, a year earlier. The latest quarter included a $599.8 million after-tax charge tied to the opioid settlement framework.
Adjusted net income fell to $251.7 million, or 48 cents a share, from $269.5 million, or 46 cents a share. Adjusted EBITDA rose to $903.4 million from $855.1 million.
Net sales and other revenue climbed to $20.3 billion from $18.8 billion, helped by about $1.4 billion of incremental sales from the extra week in the quarter. Identical sales increased 0.7%, while digital sales rose 16%. Loyalty members grew 12% to 51.2 million.
Gross margin rate slipped to 27.2% from 27.4%. Selling and administrative expenses rose to 29.6% of net sales and other revenue from 25.7%.
Interest expense increased to $141.1 million from $101.5 million. Other income fell to $6.8 million from $43.7 million.
For the full year, identical sales increased 2.0% and digital sales rose 21%. Net income was $217 million, or 40 cents a share, compared with adjusted net income of $1.209 billion, or $2.18 a share. Adjusted EBITDA was $3.902 billion. The market has reacted to these announcements by moving the company's shares 3.14% to a price of $17.09. If you want to know more, read the company's complete 8-K report here.
